Cell-Free DNA: An Upcoming Biomarker in Transplantation

Area of Science:

• Transplantation immunology
• Molecular diagnostics
• Biomarker discovery

Background:

• Donor-derived cell-free DNA (ddcfDNA) is detectable post-organ transplantation.
• Advancements in ddcfDNA quantification, like digital droplet PCR and massive parallel sequencing, enhance understanding of its behavior.

Purpose of the Study:

• To review current research on ddcfDNA in transplantation.
• To explore the clinical utility of ddcfDNA as a noninvasive rejection marker.

Main Methods:

• Literature review of published studies on ddcfDNA in organ transplantation.
• Analysis of ddcfDNA quantification techniques and their impact.

Main Results:

• Elevated ddcfDNA levels correlate with acute rejection episodes.
• Increased ddcfDNA can precede histological signs of graft rejection by weeks to months.

Conclusions:

• ddcfDNA holds significant potential as an early, noninvasive biomarker for detecting organ transplant rejection.
• Further research into ddcfDNA kinetics can refine its clinical application in post-transplant monitoring.